VoxCell BioInnovation

📍 Victoria, Canada🗓 Founded 2020👥 28 employees💰 Last funded Jun 2024
Biotechnology Research🌐 voxcellbio.com
Website LinkedIn
VoxCell BioInnovation is advancing the future of in vitro modeling. We develop 3D bioprinted, vascularized human-like tissue models that closely replicate native biology, offering a powerful tool for more predictive, physiologically relevant research. Leveraging our proprietary high-resolution bioprinter, advanced vascularization software, and Universal Bioinks™, we produce complex tissue models that mirror patient biopsy samples in structure and function. Our flagship product is a 3D vascularized model of Triple Negative Breast Cancer (TNBC), designed to support applications in disease modeling, drug screening, vascular toxicity, and targeted delivery. Delivered as ready-to-use, perfusable models, VoxCell’s consumable products serve pharmaceutical companies, biotech firms, CROs, and academic researchers seeking to reduce translational gaps and accelerate biomedical innovation.
4
Total investors
1
Early stage
3
Mid stage
0
Late stage
2020
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Canada
4
Investor activity2022–2024 · investors recorded per year
202212023120242
Recent (last 2y)Earlier
Frequently asked questions
Who invested in VoxCell BioInnovation?
VoxCell BioInnovation has 4 investors on record on gritt.io, including 1 early-stage backers, 3 mid-stage.
When did VoxCell BioInnovation last raise funding?
The most recent investment in VoxCell BioInnovation recorded on gritt.io was in June 2024.
When was VoxCell BioInnovation founded?
VoxCell BioInnovation was founded in 2020.
What industry is VoxCell BioInnovation in?
VoxCell BioInnovation operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is VoxCell BioInnovation based?
VoxCell BioInnovation is headquartered in Victoria, Canada.